Scoping Review: The Empowerment of Alzheimer’s Disease Caregivers with mHealth Applications by Kim, Eunhee et al.
Chapman University 
Chapman University Digital Commons 
Pharmacy Faculty Articles and Research School of Pharmacy 
9-7-2021 
Scoping Review: The Empowerment of Alzheimer’s Disease 
Caregivers with mHealth Applications 
Eunhee Kim 
Andrius Baskys 
Anandi V. Law 
Moom R. Roosan 
Yan Li 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.chapman.edu/pharmacy_articles 
 Part of the Clinical and Medical Social Work Commons, Health Information Technology Commons, 
Medical Neurobiology Commons, Nervous System Diseases Commons, Neurology Commons, 
Neurosciences Commons, Other Medicine and Health Sciences Commons, Other Mental and Social 
Health Commons, and the Other Psychiatry and Psychology Commons 
Scoping Review: The Empowerment of Alzheimer’s Disease Caregivers with 
mHealth Applications 
Comments 
This article was originally published in npj Digital Medicine, volume 4, in 2021. https://doi.org/10.1038/
s41746-021-00506-4 
Creative Commons License 




Eunhee Kim, Andrius Baskys, Anandi V. Law, Moom R. Roosan, Yan Li, and Don Roosan 
REVIEW ARTICLE OPEN
Scoping review: the empowerment of Alzheimer’s Disease
caregivers with mHealth applications
Eunhee Kim1, Andrius Baskys2, Anandi V. Law1, Moom R. Roosan 3, Yan Li4 and Don Roosan 1✉
Alzheimer’s Disease (AD) is one of the most prevalent neurodegenerative chronic diseases. As it progresses, patients become
increasingly dependent, and their caregivers are burdened with the increasing demand for managing their care. Mobile health
(mHealth) technology, such as smartphone applications, can support the need of these caregivers. This paper examines the
published academic literature of mHealth applications that support the caregivers of AD patients. Following the PRISMA for scoping
reviews, we searched published literature in five electronic databases between January 2014 and January 2021. Twelve articles were
included in the final review. Six themes emerged based on the functionalities provided by the reviewed applications for caregivers.
They are tracking, task management, monitoring, caregiver mental support, education, and caregiver communication platform. The
review revealed that mHealth applications for AD patients’ caregivers are inadequate. There is an opportunity for industry,
government, and academia to fill the unmet need of these caregiver.
npj Digital Medicine           (2021) 4:131 ; https://doi.org/10.1038/s41746-021-00506-4
INTRODUCTION
The global population is aging at a rapid pace. With advance-
ments in medicine and public health, one in 11 people globally
was over 65 in 2019. According to the United Nations, the number
is projected to reach one in six people by 20501. In the United
States, the population of Americans over the age of 65 is projected
to be 83.7 million in 2050, almost double the 43.1 million in 2012
according to the U.S. Census Bureau2. With the changing
population demographic, an increase in healthcare costs is
inevitable. Healthcare expenditure per capita for the population
of Americans 65 and older increased by over 50% from 1996 to
20163. Chronic conditions are primarily responsible for the higher
healthcare cost, and it is estimated that ~171 million Americans
will have at least one chronic illness by 20304. Among those,
Alzheimer’s Disease (AD) is one of the most prevalent in the
elderly population. It is estimated that people with clinical AD
would reach 9.3 million by 20605.
Despite the growing number of AD in the elderly population,
there is no cure for AD yet. Current treatment options mainly focus
on slowing down the disease progression and helping to maintain
cognitive function. For the pharmacologic treatment of AD,
cholinesterase inhibitors, such as donepezil, and an N-methyl-D-
aspartate (NMDA) receptor antagonist, memantine is used.
Majority of drugs approved by the U.S. Food and Drug
Administration (FDA) support treatment only if the patients are
in the early stages of AD. For nonpharmacologic treatments,
exercise programs and cognitive rehabilitation are used to
promote rehabilitation6,7. Thus, early detection and diagnosis of
AD can be significantly beneficial for treating the patients8.
Owing to the neurodegenerative nature of AD, Alzheimer’s
patients need an increasing amount of care as the disease
progresses9. Often, family members become the caregivers for the
patients. More than 15 million Americans provided care of AD and
other dementia patients with ~18.1 billion hours of care in 2015
alone9. Early diagnosis of AD is also crucial for caregivers, as it can
give them more time to learn about the disease and become an
integral part of planning care for the patient10.
Caregivers for AD patients often endure an enormous financial,
emotional, and physical burden. According to a recent study, 69%
of caregivers of AD patients felt a medium burden and the
patient’s severity of the disease state was a factor significantly
affecting them11. When compared with non-caregivers, caregivers
were more likely to be depressed and also utilized more negative
than positive coping strategies12. Giving support to caregivers is as
important as providing direct care to AD patients because the
well-being of caregivers is a direct indicator of the care quality
they provide10.
Caregivers need education, social support, and effective
strategies to maximize the quality of care given while maintaining
their own wellbeing. Interventions that can make caregiving easier
for the caregivers include education, counseling, support groups,
and case management support9. The core of caregiving lies in
understanding the disease and knowing how the patients will
change through the disease progression. With proper and
accessible diagnosis tools, caregivers, often one of the closest
people to the patients, can identify alerting factors that aid the
early detection of AD.
Mobile health (mHealth) applications are health-related smart-
phone applications that offer functionalities to improve patient
health13–15. mHealth applications can be designed to provide
accessible tools to support caregivers, including early AD
diagnosis. Many mHealth applications are available for AD
patients. Most of these applications are designed for patients to
self-manage AD states. For example, Backup Memory is an
application that helps AD patients remember people by saving
images of people who are known to them16, and Test Memory
Game is an application that provides memory exercise games with
shapes, numbers, and letters for AD patients16. Very few
applications are available to assist AD caregivers. The National
Institute on Aging (NIA) is currently funding 123 clinical trials
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supporting assistive devices and technology for AD and 84 trials
supporting care and caregiver interventions. However, no projects
explored mobile applications for supporting caregivers including
diagnostic tools17. Thus, there is a gap in the literature to design
and develop mHealth applications specifically for caregivers of AD
patients. The objective of this scoping review is to examine the
published academic literature of mHealth applications that
support the caregivers of Alzheimer’s patients.
MATERIALS AND METHODS
Data sources and search strategy
We followed the Preferred Reporting Items for Systematic reviews
and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) to
guide the literature search. We searched published literature in
English in five electronic databases, including PubMed, Embase,
Cochrane Library, Google Scholar, and IEEE Explore, between
January 2014 and September 2020. The date was extended to 22
January 2021 in the most recent research. The databases were
searched with combinations of three keywords “Alzheimer
disease,” AND “caregivers,” AND “mobile applications” and their
synonyms (see Fig. 1). An initial screening removed all duplicates.
Then we examined the title and abstract of these non-duplicated
articles based on the inclusion and exclusion criteria (see Table 1).
Finally, full-text reviews were performed on the remaining articles
and a total of 12 studies were included in our final review (see
Fig. 2). Two researchers independently performed data charting.
Data extraction and analysis
The review of the titles and abstracts of the non-duplicated articles
identified potential articles that meet the inclusion and exclusion
criteria. Full-text articles were then reviewed to extract data about the
mHealth applications, specifically the platform system, the objectivity
of the application (see Table 2), and application specifications for
caregiver support. After the application specifications were extracted,
six themes emerged based on the types of support provided by
these applications (see Table 3). Two independent reviewers
performed the extraction and grouping, and a third reviewer verified
the work. All results were cross-examined and checked for accuracy.
If there were any conflicts in reaching a consensus for any articles, a
third reviewer resolved conflicts.
RESULTS
A total of 351 non-duplicate articles were collected from the initial
search, of which 18 articles were eligible for full-text screening based
on title and abstract. After the full-text screening, 12 articles were
included for the final review. No additional articles were identified
from reviewing the references of relevant articles. Table 2 provides a
summary of articles included in this scoping review.
The review identified six themes (see Table 3) based on the
types of caregiving support functionalities that the applications
provided for caregivers of AD patients. The six themes are
tracking, task management, monitoring, caregiver mental support,
education, and caregiver communication platform. Some func-
tionalities were explicitly designed for the caregivers themselves
through education and mental support, whereas some provided
caregiving support through better patient management, such as
patient monitoring. Many applications included overlapping
functions. Details of each theme are discussed below.
Tracking
Tracking of the AD patient was featured in 9 out of the 12 (75%)
applications18–26. The most identifiable symptom of AD is
forgetfulness and memory loss. AD patients are at risk of getting
lost and not being able to find their way back home. Eight
applications track the patient’s current location, allowing care-
givers to check at any given time19–26. Only one application,
AlzSense, offered tracking by keeping a history of the patient’s
location changes by date and time18. In addition, three applica-
tions offered an alert system for caregivers. For example,
the application by A. Ghanem et al.20 provided a function where
the patient can enable an emergency alert system to notify the
caregiver of their location. With Acompáñame21, the caregiver can
define a geographical zone that is deemed safe for the patient to
Fig. 1 Database search queries. This figure shows the keywords used in each electronic database for the literature search for mobile
applications for caregivers of Alzheimer’s patients.
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move about in, and the application will alert the caregiver when
the patient goes outside the defined zone. Acompáñame also can
help locate nearby places such as a hospital in case of an
emergency21.
Task management
Features that help task management of caregivers were included
in 8 out of 12 (66.7%) applications19,20,22–25,27,28. As AD progresses
and the patient becomes increasingly dependent on the caregiver
to carry out daily activities, the caregiver is burdened with
essential tasks for two people. Six applications allowed the
caregivers to add daily tasks from appointments to the medication
schedule19,23–25,27,28. These applications would send an automatic
task reminder alert to the caregiver. The other two applications,
CareD and the application by A. Ghanem et al.,20,22 require the
caregivers to set up reminders for the patients. For example, the
caregivers would set up timed alerts for when the patient should
take medications or perform a daily task. Such a feature is
beneficial for more independent AD patients in the earlier stages
of the disease.
Monitoring
The monitoring of care recipients was featured in five out of 12
(41.7%) applications18,19,25,26,29. This functionality can be further
classified into three subcategories—patient activity, patient
environment, and patient health parameters. Four applications
offered just one of the monitoring categories, whereas AlzSense18
offered two different monitoring categories. For monitoring
patient activity, AlzSense18 tracks the patient’s movement (e.g.,
falls) and sends the updated information to the caregiver,
Table 1. Inclusion and exclusion criteria for articles included in the final review.
Exclusion criteria Inclusion criteria
Articles published between 1 January 2014 and 22 January 2020 Articles not available in full text
Articles available in full text Articles not published in English
Articles published in English Review papers
Articles addressing caregivers of Alzheimer’s patients Articles including digital tools but not mobile applications
Articles addressing mobile applications specifically as support
tools for caregivers
Articles not addressing caregivers of Alzheimer’s patients
Articles addressing the contents of mobile applications that
facilitate caregiving
Articles focusing on digital tools to support the care recipients and not
the caregivers
Articles not specifying the contents of mobile applications that facilitate
caregiving
Fig. 2 The flowchart of the search for eligible studies. This flowchart shows the steps of how the 12 articles for the review of mobile
applications for caregivers of Alzheimer’s patients were extracted from five electronic databases incorporating the inclusion and exclusion
criteria.
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whereas the application by D. Surendran et al.26 tracks the
patient’s movement that can be analyzed for patterns. Only one
application, AlzSense18, tracks the patient’s environment tem-
perature and humidity and sends the information to the
caregiver. Three applications that track patient health parameters,
including SMAI Caregiver, iCare, and Care IT met the criteria. With
SMAI Caregiver25, caregivers can record the patient’s blood
pressure and blood sugar readings on the application. Caregivers
can also keep a record of the patient’s behavior, eating routine,
and urination. With iCare19, the application monitors the patient’s
heart rate that the caregivers can view at any time, Care IT29
allows caregivers to monitor and record the changes in the
patient’s symptoms. All these monitoring parameters can be
shared with the patient’s providers for better management of
AD care.
Caregiver mental support
Our review only identified one (8.3%) application, Care IT29, that
provides mental health support for caregivers through the self-
assessment of depression and burden using validated measures.
The study, however, did not specify what valid measures to assess
depression were used. Understanding the state of one’s mental
health and the amount of burden can accurately prompt the
caregiver to seek medical attention if needed.
Education
Three out of the 12 (25%) applications, Care IT, UnderstAID, and
AlzCare, featured an education section within the applications24,27,29.
Care IT has links to educational resources about AD that caregivers
can utilize29. UnderstAID has five modules with 15 different topics
that can be beneficial for caregivers. The modules are as follows:
Cognitive Declines, Daily Tasks, Behavioral Changes, Social Activities,
and You as a Caregiver. These modules cover topics for caregiving
as well as caring for oneself as a caregiver. They provide videos and
images in addition to text and offer links to other websites for more
information27. Finally, AlzCare has a Learning & Care Giving section
in the application that contains basic information about AD
diagnosis and caregiving. The AD diagnosis information can help
caregivers accurately identify the patient’s current disease stage and
learn how to handle the patient appropriately. However, the article
does not specify what type of diagnosis information is available
through the application. AlzCare also has a news section that the
caregivers can get up-to-date information regarding care24.
Caregiver communication platform
There were two applications (16.7%) that provided communica-
tion platforms for the caregivers. UnderstAID27 featured a Social
Network section where caregivers can communicate with other
caregivers to exchange information and opinions. The purpose of
the communication platform was to allow caregivers to share their
knowledge and opinions about caregiving with other caregivers27.
This supports the need for caregivers to interact with other
caregivers in similar situations, creating an outlet for additional
mental support. Care IT29 provides a secure platform for sending
patient-related information to the patient’s physicians. Changes in
the patient’s symptoms tracked by the Care IT application can thus
be easily communicated with the physicians. Other applications
can adopt a similar platform to expand the caregiver community
and network of support for caregivers.
In addition to the six themes discussed, several mHealth
applications offered unique functionalities for the caregivers. The
application by A. Ghanem et al.20 allows caregivers to add a list of
relatives and friends that are close to the patient, including their
names, photos, and phone number. Patients can access the list
and make phone calls through the application. UnderstAID
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questionnaire about the severity of the dementia of the AD
patient, as well as the caregiver’s preferences, energy, and time
availability for learning27. Such information is important to display
personalized information to the caregivers.
As seen from the discussed themes, there were multiple types of
caregiving support offered by these applications. However, none of
them supported the incorporation of caregivers into patient care
management. There were no applications that offered diagnostic
tools for the caregivers to utilize. Although Care IT29 has a
communication platform to send patient information to physicians,
the application does not support diagnostic tools that the caregivers
can use and communicate the results with physicians.
DISCUSSION
The goal of the study was to examine mHealth applications that
support caregivers of AD patients. Following the PRISMA for
scoping reviews, we reviewed 12 published literature of mHealth
applications that support caregivers of AD patients and identified
six themes of functionalities that provide both caregiving and
emotional support for caregivers.
The most common support features (75%) in these applications
were tracking, task management, and patient monitoring.
Researchers require an understanding of task management and
task complexity to ensure that the needs of caregivers are met in
the application design30–33. Patient monitoring is also a popular
feature, whereas different applications provided different types of
monitoring parameters. These different types of patient monitor-
ing functions may be useful for caregivers34–36. Education is
another important feature that helps caregivers know what to
expect with the patient’s disease progression and informs them
about the available treatment options24,27,29,37.
One of the key findings in our review is the lack of
comprehensive features (i.e., with multiple functionality categories)
to support the caregivers. With each application providing only a
few functionalities, caregivers may need to use multiple mHealth
applications to fulfill all their needs. This may not meet the needs
of caregivers and may also deter them from using the applications
altogether. There is also inadequate mental health support for
caregivers. Most importantly, the help for the early diagnosis of AD
was not included as a feature for caregivers. On the other hand,
many mHealth applications have been designed for AD patients to
perform cognitive tests for AD diagnosis themselves. For example,
some mHealth applications have been designed to evaluate and
help enhance the cognitive skills of the patients through exercises
and problems22,24. Our review can be used to guide the design and
development of mHealth applications to provide comprehensive
support for caregivers of AD patients.
The current standard of practice for AD diagnosis includes several
cognitive tests, such as Saint Louis University Mental Status
Examination (SLUM), Standardized Mini-Mental State Examination
(SMMSE), and Montreal Cognitive Assessment Test (MoCA)38–40.
Because the diagnosis of an AD patient relies heavily on the change
in their cognitive abilities over time, these tests may need to be
repeated multiple times. Having to visit the doctor’s office to perform
these tests multiple times can frustrate the patient and subsequently
affect the test performance. Repeating the same cognitive tests can
also have a learning effect38. Both factors have been shown to
decrease the sensitivity of the tests. These cognitive tests also lack
specificity. Test results are usually given as an aggregate score and do
not specify the patient’s detailed performance in each of the eight
dimensions of cognition: visuospatial, naming, memory, attention,
language, abstraction, delayed recall, and orientation41. These issues
can be solved by integrating the cognitive tests into a mHealth
application, which can also make administering these tests easier
without compromising the integrity of the tests42,43.
As discussed earlier, caregivers are typically the first to detect
changes in the patient’s cognitive skills and can be a great
resource for the early diagnosis of AD patients. Thus, we
recommend that mHealth application support for caregivers
should include a functionality category of AD diagnosis tests.
This functionality can include both the patient’s test performance
in different cognitive dimensions and their cognitive impairment
progression over time. The caregivers can utilize this function-
ality to not only administer the cognitive tests for early detection
of cognitive impairment but also communicate the results with
the patient’s physicians to support tailored treatment options44.
We urge more research on how to digitize existing cognitive
tests into mHealth applications for caregivers of AD patients with
more active funding provided by the government and private
organizations.
Although the benefits of incorporating AD caregivers into the
patient’s care management are apparent, caregivers are often
excluded from the patient care management or are not valued as
part of the care team45–47. Many caregivers prefer to be actively
involved with decision-making processes in the steps of AD care,
from diagnosis to treatment47. For a disease characterized by
progressive cognitive impairment, the information that caregivers
can provide is invaluable. They can represent the patients and
offer insight that no other healthcare professional in the care team
can provide. Utilizing the caregivers as an asset within the
healthcare team model can improve the care quality. Substitutable
Medical Applications and Reusable Technologies (SMART) on Fast
Healthcare Interoperability Resources (FHIR) provides an open-
standards-based platform that allows a flow of information
between clinical mobile applications and electronic health records
(EHRs)48. SMART on FHIR can enable pertinent patient information
sharing between healthcare professionals and caregivers through
their mobile clinical applications48,49. FHIR makes it possible for
caregivers to access EHR with appropriate security measures. In
addition, technology platforms that enable the sharing of patient
health information in compliance with the Health Insurance
Portability and Accountability Act (HIPAA) provide grounds for
developing and deploying secure mHealth applications48,49.
Limitations
The absence of quality assessment of reviewed mHealth applica-
tions is a major limitation of this review, although it is not the
focus of the study. There are no regulations or standards of quality
assessment for mHealth applications, making it difficult to assess
their quality50. For information-based content, such as education
about the disease state, evaluation of the accuracy of the
information presented is necessary. Thus, further research is
needed to evaluate the quality of mHealth applications for
caregivers of AD patients.
Furthermore, this review did not assess any caregiver’s opinions
or engagement on the mobile applications. It is necessary to
understand the need of caregivers to ensure the proper design of
these applications. Future research should investigate if these
mHealth applications reflect the demand of the targeted
population while maintaining the quality and the accuracy of
information. Finally, this review only examined mHealth applica-
tions through published academic literature. It also did not include
any other digital tools independently available without smart-
phones. Feature research may include mHealth applications
designed by practitioners or have not gone through a peer-
review process.
CONCLUSION
In this study, we reviewed literature consisting of 12 mHealth
applications that provide support for caregivers of AD patients. We
identified six themes of application functionalities, which are
tracking, task management, monitoring, caregiver mental support,
education, and caregiver communication platform. Among these
E. Kim et al.
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features, tracking, task management, and monitoring were the
most common. Our finding indicates that mHealth applications
available for caregivers of AD patients are inadequate in terms of
lack of comprehensive support, and the absence of functionalities
for early AD diagnosis and the integration of caregivers in the
patient’s care management. To accommodate the increasing
number of caregivers due to the aging population, further
research needs to expand caregivers’ roles in the care manage-
ment of AD patients.
DATA AVAILABILITY
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